drugset / Trial / NCT05041270

Epidural Nalbuphine Versus Dexmedetomidine as Adjuvants to Bupivacaine in Lower Limb Surgeries

NCT05041270

Completed 23 enrolled Zagazig University
RandomizedParallel-groupTriple-blindTreatment

Summary

Combined spinal epidural anesthesia (CSE) with bupivacaine alone is not sufficient to cover pain sequel during lower limb surgeries. Previous studies used addition of either Nalbuphine or dexmedetomidine to bupivacaine in epidural anesthesia giving a good result in pain control. In this study the investigators will evaluate and compare the addition of either Nalbuphine or dexmedetomidine to bupivacaine in epidural anesthesia to evaluate the analgesic efficacy of either drug.

Timeline

Start
2021-10-01
Primary completion
2022-04-30
Completion
2022-05-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 20 ug Other
Comparator Nalbuphine Small molecule 2 mg Other

Indications

No indication recorded.